Inventor
CUIXIAN LIU
Inventor
US
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes23%
Y02ATechnologies for adaptation to climate change15%
C07CAcyclic or carbocyclic compounds10%
PatentTitleYear
12,590,087Inhibiting USP36202612,479,807Methods using HDAC11 inhibitors202512,264,1373-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors202511,919,839Alpha-cinnamide compounds and compositions as HDAC8 inhibitors202411,891,3653-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors202411,414,392[6,6] fused bicyclic HDAC8 inhibitors202211,345,672Methods using HDAC11 inhibitors202211,279,6813-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors202211,274,0843-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors202211,274,0853-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors202211,247,987Inhibiting ubiquitin specific peptidase 302022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to VALO HEALTH INC (10)· patent assignee history
2022Patents assigned to FORMA THERAPEUTICS INC (1)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VALO HEALTH INC | 10 | 2022–2026 |
| FORMA THERAPEUTICS INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 11 | 2022–2026 |